Works matching IS 02683369 AND DT 2010 AND VI 45 AND IP 3

Results: 34

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 464, doi. 10.1038/bmt.2009.178

By:

Fleskens, A. J. H. M.;
Lalisang, R. I.;
Bos, G. M. J.;
van Gelder, M.;
Jansen, R. L. H.;
Schouten, H. C.

Publication type:

Article

Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 442, doi. 10.1038/bmt.2009.179

By:

Guérin, V.;
Dalle, J.-H.;
Pédron, B.;
Ouachée-Chardin, M.;
Yakouben, K.;
Baruchel, A.;
Sterkers, G.

Publication type:

Article

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 534, doi. 10.1038/bmt.2009.180

By:

Piñana, J. L.;
Martino, R.;
Barba, P.;
Margall, N.;
Roig, M. C.;
Valcárcel, D.;
Sierra, J.;
Rabella, N.

Publication type:

Article

Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 521, doi. 10.1038/bmt.2009.187

By:

Orasch, C.;
Weisser, M.;
Mertz, D.;
Conen, A.;
Heim, D.;
Christen, S.;
Gratwohl, A.;
Battegay, M.;
Widmer, A.;
Flückiger, U.

Publication type:

Article

Barriers to mental health service use among hematopoietic SCT survivors.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 570, doi. 10.1038/bmt.2009.166

By:

Mosher, C. E.;
DuHamel, K. N.;
Rini, C. M.;
Li, Y.;
Isola, L.;
Labay, L.;
Rowley, S.;
Papadopoulos, E.;
Moskowitz, C.;
Scigliano, E.;
Grosskreutz, C.;
Redd, W. H.

Publication type:

Article

Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.

Published in:

2010

By:

Delhaes, L.;
Mraz, J.-C.;
Fréalle, E.;
Durand-Joly, I.;
Magro, L.;
Ajzenberg, D.;
Dardé, M.-L.;
Dei-Cas, E.;
Yakoub-Agha, I.

Publication type:

Case Study

Allo-SCT for hematological malignancies in the setting of HIV.

Published in:

2010

By:

Polizzotto, M. N.;
Skinner, M.;
Cole-Sinclair, M. F.;
Opat, S. S.;
Spencer, A.;
Avery, S.

Publication type:

Case Study

Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial).

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 587, doi. 10.1038/bmt.2009.170

By:

Keever-Taylor, C. A.;
Wagner, J. E.;
Kernan, N. A.;
Small, T. N.;
Carter, S. L.;
Thompson, J. S.;
Cloud, G. A.;
Lamb, L. S.

Publication type:

Article

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 543, doi. 10.1038/bmt.2009.172

By:

Tormo, N.;
Solano, C.;
Benet, I.;
Clari, M. A.;
Nieto, J.;
de la Cámara, R.;
López, J.;
López-Aldeguer, N.;
Hernández-Boluda, J. C.;
Remigia, M. J.;
Garcia-Noblejas, A.;
Gimeno, C.;
Navarro, D.

Publication type:

Article

Pancreatic atrophy is associated with gastrointestinal chronic GVHD following allogeneic PBSC transplantation.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 590, doi. 10.1038/bmt.2009.171

By:

Nakasone, H.;
Ito, A.;
Endo, H.;
Kida, M.;
Koji, I.;
Usuki, K.

Publication type:

Article

Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 565, doi. 10.1038/bmt.2009.173

By:

Ogawa, Y.;
Dogru, M.;
Uchino, M.;
Tatematsu, Y.;
Kamoi, M.;
Yamamoto, Y.;
Ogawa, J.;
Ishida, R.;
Kaido, M.;
Hara, S.;
Matsumoto, Y.;
Kawakita, T.;
Okamoto, S.;
Tsubota, K.

Publication type:

Article

Decisions to register for the National Marrow Donor Program: rational vs emotional appeals.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 422, doi. 10.1038/bmt.2009.174

By:

Studts, J. L.;
Ruberg, J. L.;
McGuffin, S. A.;
Roetzer, L. M.

Publication type:

Article

CR represents an early index of potential long survival in multiple myeloma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 498, doi. 10.1038/bmt.2009.176

By:

Wang, M.;
Delasalle, K.;
Feng, L.;
Thomas, S.;
Giralt, S.;
Qazilbash, M.;
Handy, B.;
Lee, J. J.;
Alexanian, R.

Publication type:

Article

Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 483, doi. 10.1038/bmt.2009.184

By:

Burdach, S.;
Thiel, U.;
Schöniger, M.;
Haase, R.;
Wawer, A.;
Nathrath, M.;
Kabisch, H.;
Urban, C.;
Laws, H. J.;
Dirksen, U.;
Steinborn, M.;
Dunst, J.;
Jürgens, H.

Publication type:

Article

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 558, doi. 10.1038/bmt.2009.177

By:

Chalandon, Y.;
Passweg, J. R.;
Schmid, C.;
Olavarria, E.;
Dazzi, F.;
Simula, M. P.;
Ljungman, P.;
Schattenberg, A.;
de Witte, T.;
Lenhoff, S.;
Jacobs, P.;
Volin, L.;
Iacobelli, S.;
Finke, J.;
Niederwieser, D.;
Guglielmi, C.

Publication type:

Article

Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 527, doi. 10.1038/bmt.2009.182

By:

Gesundheit, B.;
Budowski, E.;
Israeli, M.;
Shapira, M. Y.;
Resnick, I. B.;
Bringer, R.;
Azar, Y.;
Samuel, S.;
Dray, L.;
Amar, A.;
Kristt, D.;
Or, R.

Publication type:

Article

Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 550, doi. 10.1038/bmt.2009.185

By:

Han, T. H.;
Tang, Y.;
Park, Y. H.;
Maynard, J.;
Li, P.;
Akbulut, H.;
Petersen, L.;
Deisseroth, A.

Publication type:

Article

Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT.

Published in:

2010

By:

Airas, L.;
Päivärinta, M.;
Röyttä, M.;
Karhu, J.;
Kauppila, M.;
Itälä-Remes, M.;
Remes, K.

Publication type:

Case Study

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 490, doi. 10.1038/bmt.2009.181

By:

Litzow, M. R.;
Peethambaram, P. P.;
Safgren, S. L.;
Keeney, G. L.;
Ansell, S. M.;
Dispenzieri, A.;
Elliott, M. A.;
Gastineau, D. A.;
Gertz, M. A.;
Inwards, D. J.;
Lacy, M. Q.;
Micallef, I. N. M.;
Porrata, L. F.;
Lingle, W. L.;
Hartmann, L. C.;
Frost, M. H.;
Barrette, B. A.;
Long, H. J.;
Suman, V. J.;
Reid, J. M.

Publication type:

Article

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 458, doi. 10.1038/bmt.2009.188

By:

Bacigalupo, A.;
Soraru, M.;
Dominietto, A.;
Pozzi, S.;
Geroldi, S.;
Van Lint, M. T.;
Ibatici, A.;
Raiola, A. M.;
Frassoni, F.;
De Stefano, F.;
Verdiani, S.;
Casarino, L.;
Barosi, G.

Publication type:

Article

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 429, doi. 10.1038/bmt.2009.189

By:

Ciurea, S. O.;
Saliba, R.;
Rondon, G.;
Pesoa, S.;
Cano, P.;
Fernandez-Vina, M.;
Qureshi, S.;
Worth, L. L.;
McMannis, J.;
Kebriaei, P.;
Jones, R. B.;
Korbling, M.;
Qazilbash, M.;
Shpall, E. J.;
Giralt, S.;
Lima, M. de;
Champlin, R. E.;
Gajewski, J.

Publication type:

Article

MSC for the improvement of hematopoietic engraftment.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 605, doi. 10.1038/bmt.2009.199

By:

Resnick, I.;
Stepensky, P.;
Elkin, G.;
Barkatz, C.;
Gurevich, O.;
Prigozhina, T.;
Pikarsky, E.;
Waldman, E.;
Amar, A.;
Samuel, S.;
Shapira, M.;
Weintraub, M.;
Or, R.

Publication type:

Article

Potential role of adoptively transferred allogeneic WT1-specific CD4+ and CD8+ T lymphocytes for the sustained remission of refractory AML.

Published in:

2010

By:

Kim, Y.-J.;
Cho, S.-G.;
Lee, S.;
Kim, M.-S.;
Kim, E.-K.;
Cho, B.-S.;
Sohn, H.-J.;
Choi, H. B.;
Eom, K.-S.;
Min, C.-K.;
Kim, H.-J.;
Kim, Y.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Kim, C.-C.;
Kim, T.-G.

Publication type:

Case Study

Munchausen's syndrome in the allogeneic stem cell transplantation setting: a rare but potentially devastating condition.

Published in:

2010

By:

Archambault-Grenier, M.-A.;
Roy, J.;
Beauchemin, N.;
Cohen, S.;
Lachance, S.;
Kiss, T.

Publication type:

Case Study

Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 513, doi. 10.1038/bmt.2009.194

By:

Kataoka, K.;
Nannya, Y.;
Ueda, K.;
Kumano, K.;
Takahashi, T.;
Kurokawa, M.

Publication type:

Article

Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 419, doi. 10.1038/bmt.2009.193

By:

Tefferi, A.

Publication type:

Article

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 450, doi. 10.1038/bmt.2009.190

By:

Lee, J.-H.;
Lim, S.-N.;
Kim, D.-Y.;
Kim, S. H.;
Lee, Y.-S.;
Kang, Y.-A.;
Kang, S.-I.;
Jeon, M. J.;
Seol, M.;
Seo, E.-J.;
Chi, H. S.;
Park, C. J.;
Jang, S.;
Yun, S.-C.;
Lee, K.-H.

Publication type:

Article

Bone markers after total body irradiation in childhood.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 437, doi. 10.1038/bmt.2009.198

By:

Couto-Silva, A.-C.;
Trivin, C;
Espérou, H.;
Michon, J.;
Baruchel, A.;
Souberbielle, J.-C.;
Brauner, R.

Publication type:

Article

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 476, doi. 10.1038/bmt.2009.197

By:

Akhtar, S.;
El Weshi, A.;
Rahal, M.;
Abdelsalam, M.;
Al Husseini, H.;
Maghfoor, I.

Publication type:

Article

Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 505, doi. 10.1038/bmt.2009.297

By:

Ruella, M.;
Rocci, A.;
Ricca, I.;
Carniti, C.;
Bodoni, C. Labetti;
Ladetto, M.;
Caracciolo, D.;
Boccadoro, M.;
Carlo-Stella, C.;
Corradini, P.;
Tarella, C.

Publication type:

Article

Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.

Published in:

2010

By:

Kataoka, K.;
Seo, S.;
Ota, S.;
Takahashi, T.;
Kurokawa, M.

Publication type:

Case Study

Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.

Published in:

2010

By:

Nishikawa, T.;
Okamoto, Y.;
Tanabe, T.;
Shinkoda, Y.;
Kodama, Y.;
Higashi, M.;
Hirano, H.;
Arita, K.;
Kawano, Y.

Publication type:

Case Study

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 468, doi. 10.1038/bmt.2009.234

By:

Solomon, S. R.;
Matthews, R. H.;
Barreras, A. M.;
Bashey, A.;
Manion, K. L.;
McNatt, K.;
Speckhart, D.;
Connaghan, D. G.;
Morris Jr., L. E.;
Holland, H. K.

Publication type:

Article

Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 607, doi. 10.1038/bmt.2009.200

By:

Okuya, M.;
Kurosawa, H.;
Kubota, T.;
Endoh, K.;
Ogiwara, A.;
Nonoyama, S.;
Hagisawa, S.;
Sato, Y.;
Matsushita, T.;
Fukushima, K.;
Sugita, K.;
Sato, T.;
Arisaka, O.

Publication type:

Article

Works matching IS 02683369 AND DT 2010 AND VI 45 AND IP 3

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.

Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation.

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience.

Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.

Barriers to mental health service use among hematopoietic SCT survivors.

Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.

Allo-SCT for hematological malignancies in the setting of HIV.

Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial).

Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNγ CD8<sup>+</sup> and CD4<sup>+</sup> T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients

Pancreatic atrophy is associated with gastrointestinal chronic GVHD following allogeneic PBSC transplantation.

Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.

Decisions to register for the National Marrow Donor Program: rational vs emotional appeals.

CR represents an early index of potential long survival in multiple myeloma.

Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT.

Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT.

Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors.

Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT.

Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type.

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

MSC for the improvement of hematopoietic engraftment.

Potential role of adoptively transferred allogeneic WT1-specific CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes for the sustained remission of refractory AML.

Munchausen's syndrome in the allogeneic stem cell transplantation setting: a rare but potentially devastating condition.

Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.

Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act.

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity.

Bone markers after total body irradiation in childhood.

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma.

Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.

Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.

Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.

Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM.

Hematopoietic stem cell transplantation for X-linked thrombocytopenia from a mild symptomatic carrier.